FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073313275> ?p ?o ?g. }

• W2073313275 endingPage "333" @default.
• W2073313275 startingPage "326" @default.
• W2073313275 abstract "Renin-angiotensin-aldosterone system (RAAS) inhibitors are associated with hyperkalemia, but there is little evidence demonstrating patients who receive potassium monitoring have a lower rate of hyperkalemia. To evaluate the association between potassium monitoring and serious hyperkalemia-associated adverse outcomes among patients with diabetes newly initiating RAAS inhibitor therapy. Retrospective observational study. Patients with diabetes without end-stage renal disease initiating RAAS inhibitor therapy between 2001 and 2006 at three integrated health care systems. Potassium monitoring and first hyperkalemia-associated adverse event during the initial year of therapy. Hyperkalemia-associated adverse events included hospitalizations, emergency department visits or deaths within 24 h of hyperkalemia diagnosis and/or diagnostic potassium ≥6 mmol/l. Incidence rates were calculated in person-years (p-y). We used inverse probability propensity score weighting to adjust for differences between patients with and without monitoring; Poisson regression was used to obtain adjusted relative risks. A total of 19,391 of 27,355 patients (71%) received potassium monitoring. Serious hyperkalemia-associated events occurred at an incidence rate of 10.2 per 1,000 p-y. Compared to patients without monitoring, adjusted relative risk of hyperkalemia-associated adverse events among all patients with monitoring was 0.50 (0.37, 0.66); in the subset of patients who also had chronic kidney disease (n = 2,176), adjusted relative risk was 0.29 (0.18, 0.46). Patients prescribed RAAS inhibitors who have both diabetes and chronic kidney disease and receive potassium monitoring are less likely to experience a serious hyperkalemia-associated adverse event compared to similar patients who did not receive potassium monitoring. This evidence supports existing consensus-based guidelines." @default.
• W2073313275 created "2016-06-24" @default.
• W2073313275 creator A5001777389 @default.
• W2073313275 creator A5010491340 @default.
• W2073313275 creator A5017647473 @default.
• W2073313275 creator A5022212984 @default.
• W2073313275 creator A5022433806 @default.
• W2073313275 creator A5081829680 @default.
• W2073313275 creator A5082815773 @default.
• W2073313275 creator A5086515905 @default.
• W2073313275 date "2010-01-20" @default.
• W2073313275 modified "2023-10-11" @default.
• W2073313275 title "Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring" @default.
• W2073313275 cites W1550111394 @default.
• W2073313275 cites W170303893 @default.
• W2073313275 cites W180946569 @default.
• W2073313275 cites W1966408965 @default.
• W2073313275 cites W1972412925 @default.
• W2073313275 cites W1980344681 @default.
• W2073313275 cites W1980520862 @default.
• W2073313275 cites W1982920623 @default.
• W2073313275 cites W1989244799 @default.
• W2073313275 cites W1991106789 @default.
• W2073313275 cites W2004823995 @default.
• W2073313275 cites W2006157113 @default.
• W2073313275 cites W2009187570 @default.
• W2073313275 cites W2015959379 @default.
• W2073313275 cites W2021671593 @default.
• W2073313275 cites W2023399712 @default.
• W2073313275 cites W2028546483 @default.
• W2073313275 cites W2034806082 @default.
• W2073313275 cites W2042663838 @default.
• W2073313275 cites W2044773944 @default.
• W2073313275 cites W2049397775 @default.
• W2073313275 cites W2051290728 @default.
• W2073313275 cites W2052600761 @default.
• W2073313275 cites W2055864845 @default.
• W2073313275 cites W2056108924 @default.
• W2073313275 cites W2056893352 @default.
• W2073313275 cites W2056976690 @default.
• W2073313275 cites W2061075125 @default.
• W2073313275 cites W2065923696 @default.
• W2073313275 cites W2076117260 @default.
• W2073313275 cites W2078346178 @default.
• W2073313275 cites W2091744415 @default.
• W2073313275 cites W2093767567 @default.
• W2073313275 cites W2094727696 @default.
• W2073313275 cites W2098780362 @default.
• W2073313275 cites W2111945961 @default.
• W2073313275 cites W2121756841 @default.
• W2073313275 cites W2124271128 @default.
• W2073313275 cites W2126964454 @default.
• W2073313275 cites W2133712226 @default.
• W2073313275 cites W2140543320 @default.
• W2073313275 cites W2147138248 @default.
• W2073313275 cites W2150291618 @default.
• W2073313275 cites W2157853211 @default.
• W2073313275 cites W2168458505 @default.
• W2073313275 cites W2168907840 @default.
• W2073313275 cites W2169161789 @default.
• W2073313275 cites W2312388685 @default.
• W2073313275 cites W2323458614 @default.
• W2073313275 cites W2769696378 @default.
• W2073313275 doi "https://doi.org/10.1007/s11606-009-1228-x" @default.
• W2073313275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2842549" @default.
• W2073313275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20087674" @default.
• W2073313275 hasPublicationYear "2010" @default.
• W2073313275 type Work @default.
• W2073313275 sameAs 2073313275 @default.
• W2073313275 citedByCount "63" @default.
• W2073313275 countsByYear W20733132752012 @default.
• W2073313275 countsByYear W20733132752013 @default.
• W2073313275 countsByYear W20733132752014 @default.
• W2073313275 countsByYear W20733132752015 @default.
• W2073313275 countsByYear W20733132752016 @default.
• W2073313275 countsByYear W20733132752017 @default.
• W2073313275 countsByYear W20733132752018 @default.
• W2073313275 countsByYear W20733132752019 @default.
• W2073313275 countsByYear W20733132752020 @default.
• W2073313275 countsByYear W20733132752021 @default.
• W2073313275 countsByYear W20733132752022 @default.
• W2073313275 countsByYear W20733132752023 @default.
• W2073313275 crossrefType "journal-article" @default.
• W2073313275 hasAuthorship W2073313275A5001777389 @default.
• W2073313275 hasAuthorship W2073313275A5010491340 @default.
• W2073313275 hasAuthorship W2073313275A5017647473 @default.
• W2073313275 hasAuthorship W2073313275A5022212984 @default.
• W2073313275 hasAuthorship W2073313275A5022433806 @default.
• W2073313275 hasAuthorship W2073313275A5081829680 @default.
• W2073313275 hasAuthorship W2073313275A5082815773 @default.
• W2073313275 hasAuthorship W2073313275A5086515905 @default.
• W2073313275 hasBestOaLocation W20733132752 @default.
• W2073313275 hasConcept C120665830 @default.
• W2073313275 hasConcept C121332964 @default.
• W2073313275 hasConcept C126322002 @default.
• W2073313275 hasConcept C134018914 @default.
• W2073313275 hasConcept C167135981 @default.
• W2073313275 hasConcept C177713679 @default.

• next